Andere talen Respiri Limited

Aandelen

Vertraagde tijd Australian S.E. Andere beurzen 02:37:05 06-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,032 ^AUD	-5,88%		-8,57%	+6,67%

30/04	Respiri haalt AU$1,6 miljoen op via plaatsing	MT
18/04	Transcript : Respiri Limited - Shareholder/Analyst Call

Respiri to Raise AU$1.6 Million via Placement	30/04
Respiri Partners with Hawaii Independent Physician Association for Remote Patient Monitoring Program; Shares Up 3%	29/04
Respiri Limited Reports Earnings Results for the Half Year Ended December 31, 2023	29/02
Respiri Limited Announces Executive Changes	28/01
Respiri Signs Deal to Integrate Echo IQ’s Cardiovascular Technology to Remote Monitoring System; Shares Fall 4%	25/01
Respiri Limited Appoints Tom Takubo as Non-Executive Director	13/12
Respiri Limited Announces Resignation of Brian Leedman as Non-Executive Director	03/11
Respiri Limited Secures Two Additional Healthcare Provider Contract	29-09-23
Australian Bourse Halts Trading in Respiri’s Securities	14-09-23
Respiri Limited Reports Earnings Results for the Full Year Ended June 30, 2023	31-08-23
Respiri Completes Access Manages Services Acquisition	14-08-23
Respiri Completes AU$3 Million Share Purchase Plan	08-08-23
Respiri Extends Closing Date of Share Purchase Plan	25-07-23
Respiri Signs Marketing Agreement for Wheezo Device with Fi-Med Management	10-07-23
Respiri Limited Appoints Brian Leedman as Non-Executive Director	23-05-23
Respiri Appoints Chief Commercial Officer for US Market	12-04-23
Respiri Limited Appoints William Sigsbee as Chief Commercial Officer for the US Market	12-04-23
L'agenda di domani	27-02-23
Respiri Limited Reports Earnings Results for the Half Year Ended December 31, 2022	27-02-23
L'agenda della settimana	27-02-23

Geen resultaten voor deze zoekopdracht